Analyst picks & changes

SangStat Medical Corp.

(SANG)

Piper Jaffray's Hoffman said she expects FDA approval of SANG's Cross-Stat pre-transplant diagnostic around mid-year. The Menlo Park, Calif.,

Read the full 234 word article

How to gain access

Continue reading with a
two-week free trial.